IGF2BP3 and nonpapillary renal cell carcinoma: Pull‐down assays by NCAPH probes further affirmed the interaction between NCAPH mRNA and METTL3, YTHDC1 and IGF2BP3 in both ccRCC cell lines (Figure 3I).